Search Results - "Williams, Pernell"

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study by Gaudinski, Martin R, Coates, Emily E, Novik, Laura, Widge, Alicia, Houser, Katherine V, Burch, Eugeania, Holman, LaSonji A, Gordon, Ingelise J, Chen, Grace L, Carter, Cristina, Nason, Martha, Sitar, Sandra, Yamshchikov, Galina, Berkowitz, Nina, Andrews, Charla, Vazquez, Sandra, Laurencot, Carolyn, Misasi, John, Arnold, Frank, Carlton, Kevin, Lawlor, Heather, Gall, Jason, Bailer, Robert T, McDermott, Adrian, Capparelli, Edmund, Koup, Richard A, Mascola, John R, Graham, Barney S, Sullivan, Nancy J, Ledgerwood, Julie E, Hendel, Cynthia Starr, Plummer, Sarah H., Costner, Pamela, Saunders, Jamie, Mendoza, Floreliz, Eshun, Aba Mensima, Casazza, Joseph, Ola, Abidemi, Whalen, William, Wang, Xiaolin, Cunningham, Jennifer, Vasilenko, Olga, Boyd, Catina R., Trofymenko, Olga, Burgos Florez, Maria Claudia, Hickman, Somia, Rothwell, Ro Shauna, Pittman, Iris R, Le, Lam Ngan, Larkin, Brenda D, Cox, Josephine H, Apte, Preeti J, Hicks, Renunda T, Trelles Cartagena, Cora, Williams, Pernell V, Requilman, LaShawn, Nguyen, Thuy, Tran, Colin, Vazquez, Sandra, Conan-Cibotti, Michelle, Stein, Judy, Beresnev, Tatiana

“…mAb114 is a single monoclonal antibody that targets the receptor-binding domain of Ebola virus glycoprotein, which prevents mortality in rhesus macaques…”
Get full text

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial by Gaudinski, Martin R, Houser, Katherine V, Doria-Rose, Nicole A, Chen, Grace L, Rothwell, Ro Shauna S, Berkowitz, Nina, Costner, Pamela, Holman, LaSonji A, Gordon, Ingelise J, Hendel, Cynthia S, Kaltovich, Florence, Conan-Cibotti, Michelle, Gomez Lorenzo, Margarita, Carter, Cristina, Sitar, Sandra, Carlton, Kevin, Gall, Jason, Laurencot, Carolyn, Lin, Bob C, Bailer, Robert T, McDermott, Adrian B, Ko, Sung-Youl, Pegu, Amarendra, Kwon, Young D, Kwong, Peter D, Namboodiri, Aryan M, Pandey, Janardan P, Schwartz, Richard, Arnold, Frank, Hu, Zonghui, Zhang, Lily, Huang, Yunda, Koup, Richard A, Capparelli, Edmund V, Graham, Barney S, Mascola, John R, Ledgerwood, Julie E, Mendoza, Floreliz, Novik, Laura, Zephir, Kathy, Whalen, William, Larkin, Brenda, Saunders, Jamie, Cunningham, Jennifer, Levinson, Carol, Wang, Xiaolin, Plummer, Sarah, Victorino, Milalynn, Ola, Abidemi, Boyd, Catina, Jayasinghe, Nilusha, Apte, Preeti, Cartagena, Cora Trelles, Hicks, Renunda, Williams, Pernell, Vasilenko, Olga, Yamshchikov, Galina, Florez, Maria Burgos, Pittman, Iris, Gama, Lucio, Casazza, Joseph, DeCederfelt, Hope, Cheng, KC, Stein, Judy

“…Human monoclonal antibodies that potently and broadly neutralise HIV-1 are under development to prevent and treat HIV-1 infection. In this phase 1 clinical…”
Get full text